| ||Top Stories|| |
MUSC SCTR Institute Program Funding Opportunity - NIH NCATS Clinical & Translational Science Award (CTSA) - Request for Applications
The MUSC SCTR Institute is currently planning a competing renewal application to be submitted in January 2019, with a project period limited to 5 years. As part of this competing renewal, two opti onal programs will also be submitted with this application. This announcement is a request for applications from eligible MUSC faculty to direct an optionalprogram in SCTR’s grant renewal. Applications will be reviewed by SCTR leadership and internal advisors who will choose two optional programs to be included with the competing renewal application.
What Is An Optional Program?
An optional program of a Clinical and Translational Science Award is designed to supplement specific strengths and needs of the particular proposed CTSA Program hub (SCTR Institute). Each proposed optional program will require its own component. Examples of possible optional programs include genomics, phenotyping, biomarkers, drug discovery, preclinical development, imaging, or collaboration with Schools of Veterinary Medicine, rural health/telemedicine and others. Optional programs need to be feasible based upon unique opportunity and substantial prior experience. These optional programs may also focus on collaborations with other CTSA Program Hubs, for example to evaluate the effect of a new or existing tool or method on clinical and translational research at multiple hubs. Whenever possible, applicants should consider an experimental approach to evaluating innovations. Different components of one CTSA Program Hub, or several collaborating CTSAs could, for example, be randomized or cluster-randomized to the innovative approach, and then prospectively compared to those randomized to standard practice. This will allow for subsequent datadriven decision making.
Application Due: Friday, April 20, 2018
Anticipated Notification of Acceptance: Friday, May 4, 2018
Contact for Questions:
Ford Simmons III, MLIS
Special Projects Coordinator
South Carolina Clinical & Translational Research Institute
2018 Annual SCTR Mentorship Training Symposium
SCTR and the Mentor Leadership Council invite all MUSC faculty, trainees, and students to the 2018 Annual SCTR Mentorship Training Symposium: “Practical Approaches to Mentoring Challenges.” The event will feature keynote speaker Rick McGee, Jr, PhD, Associate Dean for Faculty Recruitment & Professional Development and Professor of Medical Education at Northwestern University. Dr. McGee's presentation is entitled "Mentoring 2.0: Mentors, Coaches and Shared Responsibility".
Other parts of the program will include practical tips on mentoring from three previous Peggy Schachte Mentoring Award winners, a panel discussion by successful mentor-mentee pairs in various academic tracks (research, clinical and education), and discussion of mentoring case studies. The symposium will be held on Friday, June 8, 2018, 8:30am-1pm in the Bioengineering Auditorium. Registration is free, but required. Please register at https://redcap.musc.edu/surveys/?s=7797Y9CAXH.
SCTR TL1 (T32) Predoctoral Clinical & Translational Research Training Program
April 27, 2018 at 5pm
The NIH-funded pre-doctoral training program is designed to increase the number of well-trained translational researchers who also will assume leadership roles. The program is designed for PhD and dual degree candidates with strong interest in clinical and translational research careers. The training program will provide
early exposure and appropriate training in clinical/translational research methodology, the application of cutting edge technology to clinical research, and address pipeline issues by stimulating interest from doctoral students in health- and disease-related disciplines. The program combines rigorous research experiences and a complementary didactic curriculum with a team science approach. TL1 trainees pursue research training on a full-time basis, defined by NIH as 40 hours per week, 100% time and effort. Appointments are normally 12 months and no less than 9 months. They may not work outside of their research area.
The TL1 Program provides:
- Stipend support at the NRSA-established rate for pre-doctoral trainees. Mentors are required to supplement the trainee’s stipend up to the amount required by their respective colleges.
- Tuition Support (Fall & Spring Only)
- Up to $4,200 for research/training-related expenses
- Up to $1,500 for travel to the national Association for Clinical and Translational Science (ACTS)
- Customized Individual Development Plan (IDP)http://academicdepartments.musc.edu/sctr/education_training/idp.pdf
- Support to develop an extramural fellowship training grant application
- Access to SCTR consultation, services and staff including, but not limited to: SUCCESS Center research navigation, biostatistics, subject recruitment, REDCap data capture software, animal/human subject regulatory consults, protocol development consults, NIH Public Access compliance (publications in PubMed Central), intellectual property consults and forms
- Exposure to the processes related to clinical/translational research
- Experience working as part of a team
- Exposure to clinical medicine related to the trainee’s research project
- Instruction on writing a R21 translational research grant based on the trainee’s dissertation research
- Learning about all aspects of grant management
For more information, please visit our website or contact Bridget Micka at email@example.com.
SCTR KL2 (K12) Multidisciplinary Scholars Program in Clinical & Translational Science - Application Opens March 1
Application Deadline: April 30, 2018 @ 5pm
Anticipated Start Date: July 1, 2018
The goal of the SCTR KL2 program is to foster the discipline of clinical research and increase clinical research capacity through the training of junior faculty, bridging clinical and translational research training with research independence. The SCTR KL2 will provide mentored, protected research experiences to enhance the development and retention of early career investigators. The program includes the option to pursue a master’s degree in clinical or translational science, a supportive environment, start-up research funds, and access to program faculty who will provide expertise and guidance in research design, measurement and questionnaire design, study coordination, data
management, biostatistical analysis, publishing and presenting research, and grant writing.
• Scholar Salary Support – up to $100,000.00 plus fringe at required 75% effort for two years
• Annual Research Budget – $25,000.00 to purchase research supplies and small equipment
• Travel Support – $1,000.00 to attend the Annual Translational Science Meeting in Washington, DC in April
• Individual Development Plan (IDP) – guidance and mentorship with oversight by the KL2 Program Directors
• Facilitated Externships and Experiential Training – with collaborating CTSAs and Industry
• Extramural Grant Application Support – to fund research at the conclusion of the KL2 funding; appointed scholars are required to apply for individual mentored K awards (e.g., K07, K08, K22, K23) or (preferably) independent R-series awards (R01, R03, R21) during the KL2 program. *If successful during the KL2 program, the KL2 appointment will be terminated upon funding received from the new individual K or R award*
• Access to SCTR Consultation, Services and Staff – includes SUCCESS Center research navigation, biostatistics, subject recruitment, REDCap data capture software, animal/human-subject regulatory consults, protocol development consults, NIH Public Access compliance (publications in PubMed Central), intellectual property consults and forms
Questions related to this opportunity may be addressed to Diana Lee-Chavarria at firstname.lastname@example.org or 843-792-8205.
| ||Education & Training|| |
Upcoming SCTR Lunch and Learn Programming
SCTR Lunch and Learn: CT.gov Requirements & Results Reporting
Wednesday, June 27 from 1pm to 2pm
Whitney Lesch, MBA
MUSC SUCCESS Center Research Navigator
Toni Mauney, CCRP
MUSC SUCCESS Center Regulatory Coordinator
SCTR Lunch and Learn: Human Subject Research Audit Findings and Preventative Measures
Wednesday, May 30, 2018 - 12:00pm to 1:00pm - Bioengineering 112
Erica Ellington, CRA, CHRC
Research Compliance Manager
SCTR Lunch and Learn: Communicating Your Science to the Public
Tuesday, June 5, 2018 - 12:00pm to 1:00pm - Bioengineering 112
Media Relations Director
| || || |
Work Life Integration: Circumstances and Considerations
Learn strategies for developing resilience for a successful career
Monday, April 23rd, 2:00pm – 4:00pm
Hollings Cancer Center, Room 120
Please register: https://is.gd/workschedules
Please direct any questions to Rachel Simmons at email@example.com
| ||Funding Opportunities|| |
NIH NIDA K12 Mentored Clinical Scientists Program in Drug Abuse and Addiction
Call for Applications
Letters of Intent Due: May 1, 2018
Application Due: May 31, 2018
Anticipated Notification of Acceptance: June/July 2018
Appointment State Date: July/August 2018
A call for applications for the NIDA K12 Mentored Clinical Scientists Program in Drug Abuse and Addiction has been issued. Interested junior faculty members should submit their application no later than 5:00pm on Thursday, May 31st. The application should include the submission of a 13-page proposal including: candidate’s background, career goals and objectives; proposed career development / training activities during the award period; research plan; human subjects section; and detailed budget for the initial 12-month budget period (Specific Aims 1 page, career development/research plan combined should be 12). Applicants will be expected to have identified at least one potential mentor at the time of application. A letter of commitment from the primary mentor, the mentor’s NIH biosketch, and NIH other support page will also be required.
Interested candidates who plan on applying should provide a Letter of Intent no later than Tuesday, May 1, 2018.
Please direct this and any questions regarding this career development award or the application process to Amanda Wagner, LPC, at firstname.lastname@example.org.
Clinical and Translational Research OrBiTS Program 2018
To overcome barriers that investigators face in successful translation of their work across the research continuum, we will fund proposals from researcher/investigator teams for Overcoming Barriers to Translational Success (OrBiTS) awards. These two-year grants will enable a team of at last three investigators to hire technical staff, procure specialized equipment, purchase data sets, or hire a specialized consultant so that they could generate strong clinical and translational research programs. The OrBiTS awards are not for specific research projects, but for infrastructure that will aid clinical and translational research. We anticipate that this type of support will provide considerable help in bringing basic scientists into the clinical and translational arena or facilitate translational researchers doing clinical trials, ultimately leading to procurement of large center-type grants.
Applicants are encouraged to engage with our Community Engagement and Outreach (CEO) Core as part of the pre-submission process. Those who do not will be required to engage with the CEO prior to award commencement. Community Engagement and Outreach (CEO) Core Experts from the CEO Core will review and provide feedback on Section B, which includes a statement of the relevance of the proposed research to public health. This statement is a critical component of NIH and DE-CTR ACCEL sponsored research. The statement of relevance should use plain language that can be understood by a general, lay audience. The CEO core can be contacted at https://www.de-ctr.org/redcap/surveys/?s=PF7989REXL for assistance with framing the relevance and potential impact of projects and for connection to community partners where appropriate.
For questions about the Pilot Grant program and review process contact:
Thomas S. Buchanan, PhD, ACCEL Pilot Project leader
Heather Bittner Fagan, MD, MPH, ACCEL Community Engagement and Outreach (CEO) Core leader
Doris Duke Program to Enhance the Retention of Clinicians (PERK)
MUSC/MUHA is the recipient of an award from the Doris Duke Charitable Foundation (DDCF) through a new Fund to Retain Clinical Scientists program aimed at improving the retention and advancement of junior-level physician scientists who face special challenges of balancing their professional work with caregiving responsibilities. The objective of our program – called PERK (Program to Enhance the Retention of Clinicians) – is to provide supplemental funds to support ongoing clinical research efforts of eligible faculty.
This announcement is a request for applications from eligible faculty. Applications will be accepted on a needs-based, year-round, rolling basis, with no specified deadlines. Applications will be collected and reviewed monthly.
Questions related to this opportunity may be addressed to Diana Lee-Chavarria at email@example.com or 843-792-8205.
Science of Team Science (SciTS) and Interprofessional and/or Interdisciplinary (IP/ID) Collaborations Small Grant Program Request for Applications (RFA)
South Carolina Clinical & Translational Research (SCTR) Institute and MUSC Office of Interprofessional Initiatives
Application Deadline: has been extended to 5m on Monday, April 30, 2018 (EST)
Anticipated Start Date: June 1, 2018
Award Amount: Up to $15,000 (Direct Costs only) for a 12-month project period from the date of the Notice of Award is issued.
Primary Objective: To generate pilot data on the value and impact of SciTS and IP/ID teamwork and initiatives.
Projects may focus on, but are not limited to, direct measurement of the impact of team work on research productivity, scientific innovation, patient outcomes, patient safety, cost-effectiveness of health care or research practice, health professional educational, training and clinical care outcomes (i.e. This RFA is not specifically targeted to see how many publications and grant applications would result from a specific team but rather how a particular team’s actions or behavioral changes might result in better outcomes). Projects may also focus on team science and interprofessional research tools and methodology such as the development/validation of relevant team science and interprofessional measurement tools, approaches and/or systems.
| ||Around MUSC|| |
| || || |
MUSC Office of Research and Sponsored Programs Information Session
The April information session has been canceled.
The next information session is scheduled for May 16th, 2018, from 11:00 to 12:00 in the Institute of Psychiatry’s auditorium.
A reminder message will be sent in early May.
Southeastern Medical Device Association Emerging Technology Poster Event
The Southeastern Medical Device Association (SEMDA) is holding their annual conference in Greenville, SC on May 2 -4 (http://semda.net/conference/). The conference attracts more than 350 attendees representing industry and academia in the med device arena across the southeast and beyond, so it provides an excellent opportunity to connect with potential partners for academic researchers. We are very excited to have the conference in South Carolina this year for the first time ever, and want to be sure our state is well represented. The poster session for emerging technologies will be on May 3rd at 1:30 in the exhibit hall.